Adjusted Skeletal Muscle Index (aSMI) correlates with outcome in metastatic Renal Cancer Cell (mRCC) patients (pts) treated with first line (1L) immunotherapy (IT)Adjusted Skeletal Muscle Index (aSMI) correlates with outcome in metastatic Renal Cancer Cell (mRCC) patients (pts) treated with first line (1L) immunotherapy (IT)Adjusted Skeletal Muscle Index (aSMI) correlates with outcome in metastatic Renal Cancer Cell (mRCC) patients (pts) treated with first line (1L) immunotherapy (IT)Adjusted Skeletal Muscle Index (aSMI) correlates with outcome in metastatic Renal Cancer Cell (mRCC) patients (pts) treated with first line (1L) immunotherapy (IT)

  • HOME
  • CONGRESS VENUE
  • SCIENTIFIC PROGRAMME
  • FACULTY
  • REGISTRATIONS
  • ABSTRACTS
  • EACCME® CREDITS
  • ITALIAN ECM ACCREDITATION
  • WHY ROME
  • ACCOMMODATION
  • DINNERS
  • GENERAL INFORMATION
  • SUPPORT
  • COI
  • E-Posters
Biopsy yields in different PSA density-PI-RADS score cohorts of biopsy-naïve patients with clinically-suspected prostate cancer
Settembre 9, 2023
[18F]-FACBC PET/CT Detection of Unusual and Usual Metastases in Prostate Cancer
Settembre 9, 2023

Adjusted Skeletal Muscle Index (aSMI) correlates with outcome in metastatic Renal Cancer Cell (mRCC) patients (pts) treated with first line (1L) immunotherapy (IT)

Adjusted Skeletal Muscle Index (aSMI) correlates with outcome in metastatic Renal Cancer Cell (mRCC) patients (pts) treated with first line (1L) immunotherapy (IT)
Agresti Giuseppe, Farioli Francesco, Fiocchi Federica, Baldessari Cinzia, D'Agostino Elisa, Ligabue Guido, Torricelli Pietro
This study aims to evaluate body composition (BC) and inflammatory parameters (IFN) variations with different 1L treatments in Metastatic Renal Cell Carcinoma (mRCC).
We conducted a multicentric retrospective analysis on patients (pts) with intermediate and high risk (IMDC score) treated with tyrosine kinase inhibitors (TKI) (25 pts) or immunotherapy (IT) Ipilimumab and Nivolumab (32 pts).
General characteristics, BC and IFN were recorded at baseline and at 1rst follow-up.
BC was calculated from CT scans quantifying fat (visceral and subcutaneous) [img.1] and muscle [img.2] with (SMI) without fat infiltration (adjustedSMI) at 3L vertebral level.
grasso_002
Img 1. CT scans at 3L vertebral level with visceral and subcutaneous fat quantification
muscolo_002
Img 2. CT scans at 3L vertebral level with muscle quantification and HU sampling of pure muscle and pure fat
At diagnosis medians (m) were: BMI 24,4; age 61 years (range 25-79); neutrophils/lymphocytes ratio (NLR) 2,73; sarcopenic pts by Martin et al 2013 20% (TKI) and 25,8% (IT); SMI for male (M) was 50,68 (32,77-74,54), for female (F) 46,99 (35,81-74,26); aSMI for M was 41,91 (26,33-71,59), for F 33,79 (29,99-56,05).
SMI decreased ≥5% in 64% of TKI and 53,6% of IT (p=0,58).
Overall Survival (OS) was 12,2 months (mo) (TKI) and 35,13 mo (IT).
Progression Free Survival (PFS) was 7,47 mo (TKI) and 11,12 mo (IT).
OS was not significantly different neither in TKI nor IT depending for BMI or SMI.
Conversely, better OS was observed with low basal NLR (< m) for TKI (p=0,008) and IT (p=0,018) and with high aSMI according m and sex in IT (0,039), but not in TKI (p=0,774).
INF and BC could help to optimize tailored 1L treatment for mRCC, in particular, with IT better muscle quality and quantity seems to have a favorable impact on outcome.
Further studies are needed but these results look encouraging.
Share
E-POSTER

  • [18F]-FACBC PET/CT Detection of Unusual and Usual Metastases in Prostate Cancer
  • 3D Magnetic Resonance Imaging–based Printed Models of Prostate before and after focal therapy

  • A Review of FDA Pharmacovigilance Database to Assess the Importance of Symptoms Associated with Gadolinium Exposure (SAGE)
  • Adjusted Skeletal Muscle Index (aSMI) correlates with outcome in metastatic Renal Cancer Cell (mRCC) patients (pts) treated with first line (1L) immunotherapy (IT)
  • ARTIFICIAL INTELLIGENCE IN FEMALE PELVIS MRI: CURRENT STATUS AND FUTURE PERSPECTIVES
  • Atypical leiomyoma or sarcoma? The great dilemma of the uterine myometrial tumors
  • Biopsy yields in different PSA density-PI-RADS score cohorts of biopsy-naïve patients with clinically-suspected prostate cancer
  • Birt-Hogg-Dubé syndrome: Review of radiological imaging , screening and follow-up recommendation.
  • Chronic painful cystitis and ureteric stricture following long term recreational Ketamine use
  • Chronic pelvic pain, can MRI play a role?
  • Comparison of a deep learning-accelerated T2-weighted turbo spin echo (TSE) sequence and a standard T2-weighted TSE in prostate MRI: reduced acquisition times and comparable image quality
  • Comparison of deep learning algorithms for prostate cancer detection​ and proposal of a new contrastive learning pre-training approach
  • Congenital Urachal Anomalies: Exploring the Spectrum of Imaging Findings
  • Contrast-enhanced MRI in women with endometrial cancer: dynamic versus single-phase acquisitions
  • Development of an interpretable CT radiomics model for the diagnosis of clear cell renal cell carcinoma in small solid renal masses
  • Diagnostic approach for intra-pelvic masses mimicking gynecologic masses
  • Diagnostic dilemmas and mimics of genito-urinary infections on imaging.
  • Diagnostic Performance of ADC vs ADCratio for the diagnosis of Prostate Cancer: Α Systematic review and Meta-analysis
  • Different faces of ovarian granulosa cell tumors: spectrum of MR imaging findings
  • Differentiation between an enlarged cyst and a hydronephrosis mimicking a large cyst: a critical checking point for guiding a treatment plan in PCKD patients with symptomatic or complicated cyst
  • Differentiation of endometriomas from ovarian hemorrhagic cysts on magnetic resonance imaging – a pictorial review
  • Diffusion-weighted imaging of the urinary tract – beyond tumors
  • Do MRI Structured Reports with FIGO classifications of Fibroids Contain Adequate Information for Clinical Decision Making?​
  • Does PSA density correlate with indicators of clinically significant prostate carcinoma?
  • Efficacy of MR-guided High Intensity Focused Ultrasound (MRgHIFU) in the treatment of painful bone metastases from prostate cancer
  • ENDOPROSTHESIS PLACEMENT IN PATIENTS WITH PREVIOUS SURGERY FOR OVARIAN CANCER COMPLICATED BY UROPERITONEUM
  • Evaluation of extraprostatic neoplastic extension through Multiparametric Magnetic Resonance of the Prostate.
  • Gastric-Type Adenocarcinoma of the Uterine Cervix: Role of Magnetic Resonance Imaging for Diagnosis and Management
  • Genitourinary fluoroscopic contrast examinations: what role do they have today?
  • Gynecological Masses: Tips for Determining their Site of Origin
  • Gynecological surgery’s complication: a radiological anatomical based approach to the diagnosis
  • High density flexible coil arrays for improved SNR in prostate MRI
  • High intensity focused ultrasound (HIFU) in the treatment of cancer of the prostate – Our experience
  • How embryology knowledge can help radiologists in the differential diagnosis of Wolffian duct (WD) related pathology
  • How to differentiate endometrial polyps from endometrial carcinomas on MRI: Tips and tricks
  • Image guided thermal ablation of T1 renal cell cancer: A single centre experience.
  • Image guided thermal ablation of T1 renal cell cancer: A single centre experience.
  • IMAGING FINDING IN RENAL CELL CARCINOMA – DIAGNOSIS AND STAGING
  • Imaging findings of primary prostatic lymphoma
  • Imaging in renal cell carcinoma – (a)typical findings
  • Impact of body composition on clinical outcomes in patients with metastatic hormone sensitive prostate cancer treated with androgen deprivation therapy plus second-generation antiandrogen.
  • Incidental detection on imaging in patients with a diagnosis of prostate cancer – lucky find or poisoned chalice?
  • Incidental detection on imaging performed during the work-up via MDTs of patients with kidney cancer – lucky find or poisoned chalice?
  • Incidental findings we don’t want to miss on prostate multiparametric-MRI: a pictorial review
  • Integrating clinical data with AI to optimise biopsy decisions after prostate MRI
  • Is it a leiomyoma? Challenging cases
  • MAP score and 2D Shear Wave ultrasound as adherent perinephric fat (APF) preoperative predictors in robot-assisted partial nephrectomy
  • mp-MRI appearance of primary and secondary prostate lymphomas
  • mpMRI may improve sensitivity and specificity of low dose short time 18F-PSMA 1007 imaging on a digital PET/CT scanner in low and medium risk prostate cancer patients after radical prostatectomy with biochemical recurrence at ultra-low PSA
  • MR guided Focal therapy – Spectrum of findings since the intervention day to long term surveillance.
  • MR imaging of abdominal pain in pregnant women
  • MR imaging of uterine fibroids – a pictorial review
  • MRI appearances of granulomatous prostatitis – our experience of 18 patients and pictorial review
  • MRI Characteristics of Corpus Luteum with Ovarian Oedema: Can both ovaries be affected?
  • MRI comparison of the two most actual classifications of the Mullerian anomalies
  • MRI in the characterization of renal masses
  • New transperineal ultrasound-guided biopsy for men in whom PSA is increasing after Miles’ operation
  • Novel CT-derived biomarkers for prediction of renal split function in preoperative nephrectomy planning
  • Patho-radiological correlation of clear cell renal cancer on double energy twim-beam abdominal computed tomography and biopsy samples
  • Pelvic and extra-pelvic endometriosis: a review of indications, techniques and MRI features.
  • Pelvic floor disorders: don’t forget men!
  • Pelvic venous congestion syndrome (PVCS) in women: a neglected pathology
  • Post-contrast acute kidney injury in patients with chronic kidney disease grade IV receiving iodinated contrast for elective computed tomography following new ESUR guidelines prophylaxis
  • PRACTICAL GUIDE TO PERFORM AND REPORT AN WB-DW-MRI STUDY FOR CARCINOMATOSIS OF GYNECOLOGICAL ORIGIN
  • Preoperative MRI assessment of hematometrocolpos with vaginal septum: added value of vaginal gel usage, reporting tips with surgical correlation.
  • Prospective evaluation of PI-RADS version 2.1 for clinically significant prostate cancer detection: Local performance at a University Hospital in Chile
  • Prostate MRI – are we good enough?
  • Radiomics for predicting extraprostatic extension of prostate cancer with MRI: a systematic review and meta-analysis
  • Rare presentations of testicular germ cell tumors: a pictorial multiparametric imaging review
  • Renal Ablation – Update of Current Guidelines and Impact on the Interventionalist
  • Renal Doppler Ultrasound for the prediction of non-diabetic kidney disease in diabetic patients
  • Renal Metastasis – all over the place
  • Role of MRI with diffusion-weighted imaging (DWI) in patients with uterine cervical cancer for intracavitary brachytherapy treatment alignment
  • Small renal masses management: a guidelines screenshot.
  • Soothing the headache of pregnancy and post-partum neurological complications: A pictorial review
  • The added value of capsular enhancement sign (CES) in the extra-prostatic extension (EPE) grading system in predicting prostate cancer with extracapsular extension
  • The Adequacy of Ultrasound Guided Native Renal Biopsy
  • The assessment of the Node Reporting and Data System (Node-RADS) in patients with cervical carcinoma
  • THE NEW 2019 BOSNIAK CLASSIFICATION OF COMPLICATED RENAL CYSTS. RADIOPATHOLOGICAL CORRELATION AND CRITICAL REVIEW.
  • The Prostate Imaging Quality Score (PI-QUAL): is inter-reader agreement a factor to consider?
  • The role of MRI in vulvar cancer staging according to the ESUR guidelines
  • The Role of Prophylactic Antibiotics in Transperineal Prostate Biopsy
  • The use of an AI software tool for prostate volume measurement on MRI
  • To determine the ability of an AI software tool to detect significant prostate cancer on MRI
  • To investigate the sonographic appearance of kidneys in farmers from a population-based study performed in a rural area of central-south Chile.
  • Untangling the Mystery: Radiological Insights into Female Pelvic Organ Torsion
  • Ureteral stone size measurements in non-enhanced CT (NECT) – interreader variability and prediction of spontaneous stone passage in different window settings
  • Using Low Energy Mono-Energetic CT Reconstruction to Improve Detection of  High-Risk Prostate Cancer
  • What is the best T1-weighted Dixon protocol for diagnosis of endometriosis?

Contact us


+39 06 52247328

FEDRA CONGRESSI S.A.S.
Viale dei SS. Pietro e Paolo, 21
00144 Roma
Tel +39.0652247328
Fax +39.065205625

www.fedracongressi.com
info@fedracongressi.com

  • HOME
  • CONGRESS VENUE
  • SCIENTIFIC PROGRAMME
  • FACULTY
  • REGISTRATIONS
  • ABSTRACTS
  • EACCME® CREDITS
  • ITALIAN ECM ACCREDITATION
  • WHY ROME
  • ACCOMMODATION
  • DINNERS
  • GENERAL INFORMATION
  • SUPPORT
  • COI
  • E-Posters
© 2023 Copyright by FEDRA CONGRESSI | All Rights Reserved |